Michael Thomas Heffernan - Feb 10, 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
Director
Signature
/s/ Shirley R. Kuhlmann as Attorney-in-Fact for Michael T. Heffernan
Stock symbol
COLL
Transactions as of
Feb 10, 2025
Transactions value $
$0
Form type
4
Date filed
2/12/2025, 04:10 PM
Previous filing
Jun 14, 2024
Next filing
Mar 26, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +4.82K +10.59% $0.00 50.3K Feb 10, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock.